WuXi Biologics added to FTSE4Good Index Series for sixth straight yearPUBT·1 day ago, 09:28 PMWXXWY-3.96%02269-4.01%
WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMOPR Newswire·1 day ago, 09:27 PMWXXWY-3.96%02269-4.01%
Nomura Raises WUXI BIO TP to HKD51.38, Estimates 1H Profit to Drop 15%AASTOCKS News·Jul 27 at 02:22 AMWXXWY-3.96%02269-4.01%
WuXi Biologics schedules board meeting to review interim resultsPUBT·Jul 24 at 03:32 AMWXXWY-3.96%02269-4.01%
The 2026 Pick-and-Shovel Illusion: Who Is Actually Building the Future?Global Report·Jul 21 at 04:13 AMVMC-4.47%MLM-5.21%
SDIC Securities Keeps Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)Tip Ranks·Jul 17 at 04:55 AM02269-4.01%WXXWY-3.96%
CANbridge Calls Virtual EGM to Approve WuXi Biologics Service FrameworkTip Ranks·Jul 15 at 09:38 AM01228+0.51%WXXWY-3.96%
UBS: CN CRO Sees Solid Revenue Growth in 1H; WUXI APPTEC Top PickAASTOCKS News·Jul 14 at 02:56 AM02269-4.01%02359-0.57%
UBS' Investment Ratings and TPs on CRO Stocks (Table)AASTOCKS News·Jul 14 at 02:00 AM300759-3.25%02268-3.68%
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Community Health (CYH)businessinsider·Jul 11 at 03:00 AMWXXWY-3.96%02269-4.01%
CANbridge Pharmaceuticals delays EGM circular dispatch to on or before July 20, 2026PUBT·Jul 9 at 03:32 AM01228+0.51%WXXWY-3.96%
WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune TherapyUnusual Whales·Jul 9 at 02:34 AM02269-4.01%WXXWY-3.96%
